New York panel seeks extra Medicaid rebates from Biogen for pricey rare disease drug - STAT

New York panel seeks extra Medicaid rebates from Biogen for pricey rare disease drug - STAT

STAT stories you may have missed

New York state wants additional rebates from Biogen over its drug, Spinraza 

A San Francisco city council member is trying to strip Mark Zuckerberg’s name from a public hospital 

The generic lobby lost again in a legal battle over California’s pay-for-delay law

Moderna lost a key patent battle that could have major implications for its potential Covid-19 vaccine 

At a kick off for FDA’s user fee program, drug makers pushed the agency to make certain pandemic-induced flexibilities permanent